Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

Lifecore Biomedical has a market cap or net worth of $152.53M. The enterprise value is $278.97M.

Lifecore Biomedical has 37,477,386 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifecore Biomedical’s return on equity (ROE) is -28.98 and return on invested capital (ROIC) is -8.10%.

The current PE Ratio of Lifecore Biomedical is ―. Lifecore Biomedical’s PEG ratio is 0.01.

In the last 12 months, Lifecore Biomedical had revenue of 128.87M and earned -38.72M in profits. Earnings per share was -1.27.

In the last 12 months, operating cash flow was 13.88M and capital expenditures -11.25M, giving a free cash flow of 2.63M billion.

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Lifecore Biomedical upcoming earnings date is Apr 8, 2026, After Close (Confirmed).

Lifecore Biomedical as a current ratio of 2.84, with Debt / Equity ratio of 422.52%

In the past 12 months, Lifecore Biomedical has paid 43.00K in taxes.

Lifecore Biomedical EV to EBITDA ratio is -40.46, with an EV/FCF ratio of -26.18.

Lifecore Biomedical has $17.47M in cash and marketable securities with $143.91M in debt, giving a net cash position of -$126.44M billion.

Gross margin is 32.30%, with operating margin of -13.38%, and net profit margin of -30.04%.

The average price target for Lifecore Biomedical is $6.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy